These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36621922)

  • 21. Pituitary macroadenomas associated with hyperprolactinaemia: immunocytochemical and in-situ hybridization studies.
    McNicol AM; Walker E; Farquharson MA; Teasdale GM
    Clin Endocrinol (Oxf); 1991 Sep; 35(3):239-44. PubMed ID: 1742881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prevalence of hyperprolactinaemia and association with markers of autoimmune thyroid disease in survivors of the Whickham Survey cohort.
    Vanderpump MP; French JM; Appleton D; Tunbridge WM; Kendall-Taylor P
    Clin Endocrinol (Oxf); 1998 Jan; 48(1):39-44. PubMed ID: 9509066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The value of prolactin in predicting prolactinοma in hyperprolactinaemic polycystic ovarian syndrome.
    Kyritsi EM; Dimitriadis GK; Angelousi A; Mehta H; Shad A; Mytilinaiou M; Kaltsas G; Randeva HS
    Eur J Clin Invest; 2018 Jul; 48(7):e12961. PubMed ID: 29845629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperprolactinaemia attenuates the inhibitory effect of vitamin D/selenomethionine combination therapy on thyroid autoimmunity in euthyroid women with Hashimoto's thyroiditis: A pilot study.
    Krysiak R; Kowalcze K; Okopień B
    J Clin Pharm Ther; 2020 Dec; 45(6):1334-1341. PubMed ID: 32649802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polycystic ovary syndrome and hyperprolactinemia are distinct entities.
    Filho RB; Domingues L; Naves L; Ferraz E; Alves A; Casulari LA
    Gynecol Endocrinol; 2007 May; 23(5):267-72. PubMed ID: 17558684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical impact of hyperprolactinaemia.
    Schlechte JA
    Baillieres Clin Endocrinol Metab; 1995 Apr; 9(2):359-66. PubMed ID: 7625989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An audit of the diagnostic usefulness of PRL and TSH responses to domperidone and high resolution magnetic resonance imaging of the pituitary in the evaluation of hyperprolactinaemia.
    Sawers HA; Robb OJ; Walmsley D; Strachan FM; Shaw J; Bevan JS
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):321-6. PubMed ID: 9156042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone mineral density and bone turnover in hyperprolactinaemia of various origins.
    Zadrozna-Sliwka B; Bolanowski M; Kałuzny M; Syrycka J
    Endokrynol Pol; 2007; 58(2):116-22. PubMed ID: 17578827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prolactin profile in a cohort of Chinese systemic lupus erythematosus patients.
    Mok CC; Lau CS; Tam SC
    Br J Rheumatol; 1997 Sep; 36(9):986-9. PubMed ID: 9376996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Macroprolactin in subjects with hyperprolactinaemia: clinical observations and relations between free PRL and PRL complexed with IgG].
    Jeske W; Zgliczyński W; Gorzelak K
    Endokrynol Pol; 2005; 56(5):779-84. PubMed ID: 16817144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of hyperprolactinaemia in female premenopausal blood donors.
    Alpañés M; Sanchón R; Martínez-García MÁ; Martínez-Bermejo E; Escobar-Morreale HF
    Clin Endocrinol (Oxf); 2013 Oct; 79(4):545-9. PubMed ID: 23445257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences. Selective literature review.
    Wieck A; Haddad PM
    Br J Psychiatry; 2003 Mar; 182():199-204. PubMed ID: 12611781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of big, big prolactin in patients with hyperprolactinaemia.
    Leite V; Cosby H; Sobrinho LG; Fresnoza MA; Santos MA; Friesen HG
    Clin Endocrinol (Oxf); 1992 Oct; 37(4):365-72. PubMed ID: 1483294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperprolactinaemia and the regular menstrual cycle in asymptomatic women: should it be treated during therapy for infertility?
    Nawroth F
    Reprod Biomed Online; 2005 Nov; 11(5):581-8. PubMed ID: 16409707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperprolactinaemia and sexual function in the male.
    Bouloux PM; Grossman A
    Br J Hosp Med; 1987 Jun; 37(6):503-10. PubMed ID: 3594036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of endocrine tests. A: the TRH test in patients with hyperprolactinaemia.
    Le Moli R; Endert E; Fliers E; Prummel MF; Wiersinga WM
    Neth J Med; 2003 Feb; 61(2):44-8. PubMed ID: 12735420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of antipsychotic-induced hyperprolactinaemia on the hypothalamic-pituitary-gonadal axis.
    Smith S; Wheeler MJ; Murray R; O'Keane V
    J Clin Psychopharmacol; 2002 Apr; 22(2):109-14. PubMed ID: 11910254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperprolactinaemia does not always mean 'hyperprolactinaemia'!
    Gezer A; Atasü T; Hekim C; Stenman UH; Hekim N
    Eur J Obstet Gynecol Reprod Biol; 2005 Feb; 118(2):206-8. PubMed ID: 15653204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolactin gene expression in human growth hormone-secreting pituitary adenomas.
    Nagaya T; Seo H; Kuwayama A; Sakurai T; Tsukamoto N; Sugita K; Matsui N
    J Neurosurg; 1990 Jun; 72(6):879-82. PubMed ID: 2338572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin sensitivity and hyperprolactinemia.
    Tuzcu A; Bahceci M; Dursun M; Turgut C; Bahceci S
    J Endocrinol Invest; 2003 Apr; 26(4):341-6. PubMed ID: 12841542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.